FDA — authorised 27 February 1997
- Application: NDA020723
- Marketing authorisation holder: BAUSCH
- Local brand name: ALDARA
- Indication: CREAM — TOPICAL
- Status: approved
FDA authorised Aldara on 27 February 1997
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 27 February 1997; FDA authorised it on 27 February 1997; FDA authorised it on 25 February 2010.
BAUSCH holds the US marketing authorisation.